TD Asset Management’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-15,300
Closed -$658K 1380
2018
Q4
$658K Sell
15,300
-7,200
-32% -$336K ﹤0.01% 1162
2018
Q3
$1.11M Sell
22,500
-4,700
-17% -$203K ﹤0.01% 1134
2018
Q2
$872K Sell
27,200
-1,900
-7% -$65.6K ﹤0.01% 1163
2018
Q1
$906K Buy
29,100
+1,800
+7% +$64.1K ﹤0.01% 1084
2017
Q4
$1.25M Buy
27,300
+1,500
+6% +$59.4K ﹤0.01% 998
2017
Q3
$969K Sell
25,800
-4,763
-16% -$192K ﹤0.01% 1040
2017
Q2
$1.46M Sell
30,563
-5,700
-16% -$264K ﹤0.01% 952
2017
Q1
$1.65M Sell
36,263
-5,800
-14% -$251K ﹤0.01% 929
2016
Q4
$1.36M Sell
42,063
-20,137
-32% -$672K ﹤0.01% 948
2016
Q3
$2.13M Sell
62,200
-14,000
-18% -$548K ﹤0.01% 867
2016
Q2
$2.57M Buy
76,200
+4,200
+6% +$206K ﹤0.01% 814
2016
Q1
$3.81M Sell
72,000
-2,700
-4% -$158K 0.01% 732
2015
Q4
$5.74M Buy
74,700
+1,300
+2% +$73.6K 0.01% 612
2015
Q3
$3.02M Buy
73,400
+2,100
+3% +$129K 0.01% 750
2015
Q2
$5.04M Sell
71,300
-9,100
-11% -$717K 0.01% 674
2015
Q1
$7.14M Buy
80,400
+7,500
+10% +$761K 0.01% 575
2014
Q4
$6.46M Sell
72,900
-12,700
-15% -$1.2M 0.01% 600
2014
Q3
$8.3M Buy
85,600
+6,400
+8% +$623K 0.01% 513
2014
Q2
$7.28M Sell
79,200
-2,100
-3% -$160K 0.01% 548
2014
Q1
$5.69M Buy
81,300
+5,000
+7% +$340K 0.01% 612
2013
Q4
$4.39M Sell
76,300
-1,600
-2% -$84.1K 0.01% 665
2013
Q3
$3.75M Sell
77,900
-3,500
-4% -$128K 0.01% 680
2013
Q2
$2.36M Buy
+81,400
New +$2.35M 0.01% 738

Other funds holding PCRX